📂 Drugs
boserolimab — Definition
Boserolimab / boserolimab
Boserolimab is a monochlonal antibody aimed at programmed cell death receptor 1 (PD-1). This drug, classified as the immun control point inhibitor, is used to increase the immune response to cancer cells of T cells. Clinically, the advanced stage is researched in the treatment of solid tumors and shows antitumor activity through PD-1 road inhibition.
Frequently Asked Questions
❓ What is Boserolimab?
Boserolimab; boserolimab is a monochlonal antibody aimed at programmed cell death receptor 1 (PD-1). This drug, classified as the immun control point inhibitor, is used to increase the immune response to cancer cells of T cells. Clinically, the advanced stage is researched in the treatment of solid tumors and shows antitumor activity through PD-1 road inhibition.
❓ What is boserolimab in Turkish?
The Turkish equivalent of "boserolimab" is Boserolimab.
❓ Which medical field is Boserolimab related to?
This term belongs to the Drugs category.